메뉴 건너뛰기




Volumn 25, Issue 6, 2011, Pages 1049-1050

The t(4;9)(q11;q33) fuses CEP110 to KIT in a case of acute myeloid leukemia

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RA; PLATELET DERIVED GROWTH FACTOR RB; PROTEIN KIT; STEM CELL FACTOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

EID: 79958081050     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.40     Document Type: Article
Times cited : (3)

References (6)
  • 1
    • 70349934301 scopus 로고    scopus 로고
    • Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3
    • Masson K, Rönnstrand L. Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3. Cell Signal 2009; 21: 1717-1726.
    • (2009) Cell Signal , vol.21 , pp. 1717-1726
    • Masson, K.1    Rönnstrand, L.2
  • 2
    • 12144261476 scopus 로고    scopus 로고
    • Oncogenic derivatives of platelet-derived growth factor receptors
    • DOI 10.1007/s00018-004-4272-z
    • Jones AV, Cross NCP. Oncogenic derivatives of platelet-derived growth factor receptors. Cell Mol Life Sci 2004; 61: 2912-2923. (Pubitemid 40104589)
    • (2004) Cellular and Molecular Life Sciences , vol.61 , Issue.23 , pp. 2912-2923
    • Jones, A.V.1    Cross, N.C.P.2
  • 3
    • 33847176197 scopus 로고    scopus 로고
    • Tyrosine kinases as therapeutic targets in BCR-ABL negative chronic myeloproliferative disorders
    • Reiter A, Walz C, Cross NCP. Tyrosine kinases as therapeutic targets in BCR-ABL negative chronic myeloproliferative disorders. Curr Drug Targets 2007; 8: 205-216.
    • (2007) Curr Drug Targets , vol.8 , pp. 205-216
    • Reiter, A.1    Walz, C.2    Cross, N.C.P.3
  • 4
    • 32844458679 scopus 로고    scopus 로고
    • Translocation (4;9)(q11;q33), a new rearrangement in acute myeloid leukemia with central nervous system involvement [4]
    • DOI 10.1016/j.cancergencyto.2005.10.006, PII S0165460805006084
    • Liu YC, Sashida G, Kodama A, Ohyashiki K. Translocation (4;9)(q11;q33), a new rearrangement in acute myeloid leukemia with central nervous system involvement. Cancer Genet Cytogenet 2006; 165: 85-86. (Pubitemid 43254658)
    • (2006) Cancer Genetics and Cytogenetics , vol.165 , Issue.1 , pp. 85-86
    • Liu, Y.-C.1    Sashida, G.2    Kodama, A.3    Ohyashiki, K.4
  • 5
    • 33646152550 scopus 로고    scopus 로고
    • Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia
    • Score J, Curtis C, Waghorn K, Stalder M, Jotterand M, Grand FH et al. Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia. Leukemia 2006; 20: 827-832.
    • (2006) Leukemia , vol.20 , pp. 827-832
    • Score, J.1    Curtis, C.2    Waghorn, K.3    Stalder, M.4    Jotterand, M.5    Grand, F.H.6
  • 6
    • 0034161335 scopus 로고    scopus 로고
    • FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33)
    • Guasch G, Mack GJ, Popovici C, Dastugue N, Birnbaum D, Rattner JB et al. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33). Blood 2000; 95: 1788-1796. (Pubitemid 30120844)
    • (2000) Blood , vol.95 , Issue.5 , pp. 1788-1796
    • Guasch, G.1    Mack, G.J.2    Popovici, C.3    Dastugue, N.4    Birnbaum, D.5    Rattner, J.B.6    Pebusque, M.-J.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.